Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:28117336

CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.

Iram Fatima · Saima Sadaf · Syed Ghulam Musharraf · Naghma Hashmi · Muhammad Waheed Akhtar

Scientific reports · 2017 doi:10.1038/srep40943

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:28117336
kind
science-record
content_hash
sha256:275356f0840a5c60efe81f3992f690d4fe270264dadf409b52fdbf4329450d8d
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:22Z
updated_at
2026-11-01T21:59:15Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.
doi
10.1038/srep40943
pmid
28117336
authors array · 5 items
[0]
Iram Fatima
[1]
Saima Sadaf
[2]
Syed Ghulam Musharraf
[3]
Naghma Hashmi
[4]
Muhammad Waheed Akhtar
journal
Scientific reports
year
2017
abstract
Better and sensitive biomarkers are needed to help understand the mechanism of disease onset, progression, prognosis and monitoring of the therapeutic response. Aim of this study was to identify the candidate circulating markers of chronic-phase chronic myeloid leukemia (CP-CML) manifestations, having potential to develop into predictive- or monitoring-biomarkers. A proteomic approach, two-dimensional gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose. Based on the spot intensity measurements, six proteins were found to be consistently dysregulated in CP-CML subjects compared to the healthy controls [false discovery rate (FDR) threshold ≤0.05]. These were identified as α-1-antichymotrypsin, α-1-antitrypsin, CD5 molecule-like, stress-induced phosphoprotein 1, vitamin D binding protein isoform 1 and transthyretin by MS analysis [PMF score ≥79; data accessible via ProteomeXchange with identifier PXD002757]. Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001). Two of the circulating marker proteins, identified in this study, had not previously been associated with chronic- or acute-phase myeloid leukemia. Exploration of their probable association with CP-CML, in a larger study cohort, may add to our understanding of the disease mechanism besides developing clinically useful biomarkers in future.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28117336
locator
sections[14] "Statistical analysis and validation of biomarker candidates" paragraph 2
quote
The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28117336
locator
sections[5] "2D proteome profiling and mass spectrometric analysis" paragraph 2
quote
The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The study used two-dimensional gel electrophoresis with mass spectrometry (2DE-MS), identified differentially expressed proteins using a false discovery rate threshold ≤0.05 and peptide mass fingerprinting score ≥79, and made the proteomics data accessible through ProteomeXchange under identifier PXD002757.
kind
quantitative
target object · 4 fields
value
0.0001
unit
p-value
tolerance
null
source
Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001).
evidence array · 4 items
[0] object · 3 fields
asset
source:pmid:28117336
locator
sections[0] "Abstract" paragraph 1
quote
A proteomic approach, two-dimensional gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose.
[1] object · 3 fields
asset
source:pmid:28117336
locator
sections[0] "Abstract" paragraph 1
quote
Based on the spot intensity measurements, six proteins were found to be consistently dysregulated in CP-CML subjects compared to the healthy controls [false discovery rate (FDR) threshold ≤0.05].
[2] object · 3 fields
asset
source:pmid:28117336
locator
sections[0] "Abstract" paragraph 1
quote
These were identified as α-1-antichymotrypsin, α-1-antitrypsin, CD5 molecule-like, stress-induced phosphoprotein 1, vitamin D binding protein isoform 1 and transthyretin by MS analysis [PMF score ≥79; data accessible via ProteomeXchange with identifier PXD002757].
[3] object · 3 fields
asset
source:pmid:28117336
locator
sections[0] "Abstract" paragraph 1
quote
Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
The study used two-dimensional gel electrophoresis with mass spectrometry (2DE-MS), identified differentially expressed proteins using a false discovery rate threshold ≤0.05 and peptide mass fingerprinting score ≥79, and made the proteomics data accessible through ProteomeXchange under identifier PXD002757.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:28117336
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD002757
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:student_t
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD002757
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:student_t
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:28117336
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1038/srep40943
sha256
sha256:07a850e328f24539e27d8fd71056a8567490a462c770011dd8970e977b9fed57
bytes
25947
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1038/srep40943
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5259771
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD002757
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD002757
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD002757
version
null
note
The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
Plasma Proteome Profiling of CML in Pakistan
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:PXD002757 not downloaded
[1]
asset:data:geo:PXD002757 licence not read
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
student_t_test
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Student's t-test
[1] object · 10 fields
id
method-2
family
group_comparison
specific
mann_whitney
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_mann_whitney
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Mann-Whitney
[2] object · 10 fields
id
method-3
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.7
band
medium
quote
ANOVA
[3] object · 10 fields
id
method-4
family
null
specific
null
label
Non-parametric Mann–Whitney U test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test.
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
bootstrap_mean_difference
unit
p-value
tolerance
null
state
complete
note
The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold.
gaps array · 2 items
[0]
method.reader_named_unmapped
[1]
method.student_t
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD002757
resolved_accessions array · 1 item
[0]
PXD002757
statements array · 1 item
[0]
The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.
basis
The paper names PXD002757 in PRIDE partner repository of the ProteomeXchange Consortium and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:28117336
[1]
data:geo:PXD002757
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
student_t
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD002757
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:30:29Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
51416
completion_tokens
3489
cached_tokens
25609
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:28117336
type
paper
label
pmid:28117336
[1] object · 3 fields
id
source:pmid:28117336
type
manuscript
label
PMID 28117336 full text
[2] object · 3 fields
id
data:geo:PXD002757
type
dataset
label
GEO PXD002757
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:28117336
type
paper
label
pmid:28117336
[1] object · 3 fields
id
source:pmid:28117336
type
manuscript
label
PMID 28117336 full text
[2] object · 3 fields
id
data:geo:PXD002757
type
dataset
label
GEO PXD002757
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-28117336
type
extraction
used array · 1 item
[0]
source:pmid:28117336
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD002757
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD002757
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:28117336
parent_hash
sha256:77991e933b4619c6eea9abe457318b6c4bed6791422bbcec51ecc8265faff45c
fork_of
null
gaps array · 9 items
[0]
asset:data:geo:PXD002757 licence not read
[1]
asset:data:geo:PXD002757 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
method.student_t
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
[8]
step:run_analysis blocked on method:student_t
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
ronic myeloid leukemia - an insight from the proteomic analysis of human plasma.
[1]
into predictive- or monitoring-biomarkers. A proteomic approach, two-dimensional gel electrophoresi
[2]
onal gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose. Bas
order_basis
paper_text_order:64
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
nge with identifier PXD002757]. Quantitative ELISA, used for validation of candidate proteins b
[1]
udies by enzyme linked immunosorbant assays (ELISA). To minimize sample handling bias or pipett
[2]
andling bias or pipetting errors, pre-coated ELISA plates against human AAT (also called SERPIN
order_basis
paper_text_order:1078
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Student's t-test
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:28117336", "kind": "science-record", "revision": 7, "content_hash": "sha256:275356f0840a5c60efe81f3992f690d4fe270264dadf409b52fdbf4329450d8d", "created_at": "2026-11-01T15:40:22Z", "updated_at": "2026-11-01T21:59:15Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.", "doi": "10.1038/srep40943", "pmid": "28117336", "authors": ["Iram Fatima", "Saima Sadaf", "Syed Ghulam Musharraf", "Naghma Hashmi", "Muhammad Waheed Akhtar"], "journal": "Scientific reports", "year": 2017, "abstract": "Better and sensitive biomarkers are needed to help understand the mechanism of disease onset, progression, prognosis and monitoring of the therapeutic response. Aim of this study was to identify the candidate circulating markers of chronic-phase chronic myeloid leukemia (CP-CML) manifestations, having potential to develop into predictive- or monitoring-biomarkers. A proteomic approach, two-dimensional gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose. Based on the spot intensity measurements, six proteins were found to be consistently dysregulated in CP-CML subjects compared to the healthy controls [false discovery rate (FDR) threshold ≤0.05]. These were identified as α-1-antichymotrypsin, α-1-antitrypsin, CD5 molecule-like, stress-induced phosphoprotein 1, vitamin D binding protein isoform 1 and transthyretin by MS analysis [PMF score ≥79; data accessible via ProteomeXchange with identifier PXD002757]. Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001). Two of the circulating marker proteins, identified in this study, had not previously been associated with chronic- or acute-phase myeloid leukemia. Exploration of their probable association with CP-CML, in a larger study cohort, may add to our understanding of the disease mechanism besides developing clinically useful biomarkers in future.", "claims": [{"id": "claim-method", "statement": "The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28117336", "locator": "sections[14] \"Statistical analysis and validation of biomarker candidates\" paragraph 2", "quote": "The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28117336", "locator": "sections[5] \"2D proteome profiling and mass spectrometric analysis\" paragraph 2", "quote": "The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The study used two-dimensional gel electrophoresis with mass spectrometry (2DE-MS), identified differentially expressed proteins using a false discovery rate threshold ≤0.05 and peptide mass fingerprinting score ≥79, and made the proteomics data accessible through ProteomeXchange under identifier PXD002757.", "kind": "quantitative", "target": {"value": 0.0001, "unit": "p-value", "tolerance": null, "source": "Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001)."}, "evidence": [{"asset": "source:pmid:28117336", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "A proteomic approach, two-dimensional gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose."}, {"asset": "source:pmid:28117336", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Based on the spot intensity measurements, six proteins were found to be consistently dysregulated in CP-CML subjects compared to the healthy controls [false discovery rate (FDR) threshold ≤0.05]."}, {"asset": "source:pmid:28117336", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "These were identified as α-1-antichymotrypsin, α-1-antitrypsin, CD5 molecule-like, stress-induced phosphoprotein 1, vitamin D binding protein isoform 1 and transthyretin by MS analysis [PMF score ≥79; data accessible via ProteomeXchange with identifier PXD002757]."}, {"asset": "source:pmid:28117336", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "The study used two-dimensional gel electrophoresis with mass spectrometry (2DE-MS), identified differentially expressed proteins using a false discovery rate threshold ≤0.05 and peptide mass fingerprinting score ≥79, and made the proteomics data accessible through ProteomeXchange under identifier PXD002757.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:28117336"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD002757"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:student_t", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD002757"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:student_t"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:28117336", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1038/srep40943", "sha256": "sha256:07a850e328f24539e27d8fd71056a8567490a462c770011dd8970e977b9fed57", "bytes": 25947, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1038/srep40943", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5259771", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD002757", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD002757", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD002757", "version": null, "note": "The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Plasma Proteome Profiling of CML in Pakistan", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD002757 not downloaded", "asset:data:geo:PXD002757 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "student_t_test", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["student_t"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Student's t-test"}}, {"id": "method-2", "family": "group_comparison", "specific": "mann_whitney", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_mann_whitney"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Mann-Whitney"}}, {"id": "method-3", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.7, "band": "medium", "quote": "ANOVA"}}, {"id": "method-4", "family": null, "specific": null, "label": "Non-parametric Mann–Whitney U test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The spot intensity differences obtained from the 2D-gel images of at least 3 different sets of independent plasma samples were analyzed by non-parametric Mann-Whitney U test."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "bootstrap_mean_difference", "expected_value": 0.0001, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": ["method.reader_named_unmapped", "method.student_t"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["student_t"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD002757"], "resolved_accessions": ["PXD002757"], "statements": ["The proteomics data was deposited to the ProteomeXchange Consortium8 via PRIDE partner repository (http://www.ebi.ac.uk/pride/) with the dataset identifier PXD002757."], "basis": "The paper names PXD002757 in PRIDE partner repository of the ProteomeXchange Consortium and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:28117336", "data:geo:PXD002757"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "student_t", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD002757"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:30:29Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 51416, "completion_tokens": 3489, "cached_tokens": 25609}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:28117336", "type": "paper", "label": "pmid:28117336"}, {"id": "source:pmid:28117336", "type": "manuscript", "label": "PMID 28117336 full text"}, {"id": "data:geo:PXD002757", "type": "dataset", "label": "GEO PXD002757"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:28117336", "type": "paper", "label": "pmid:28117336"}, {"id": "source:pmid:28117336", "type": "manuscript", "label": "PMID 28117336 full text"}, {"id": "data:geo:PXD002757", "type": "dataset", "label": "GEO PXD002757"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-28117336", "type": "extraction", "used": ["source:pmid:28117336"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD002757", "type": "accession_resolution", "used": ["data:geo:PXD002757"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:28117336", "parent_hash": "sha256:77991e933b4619c6eea9abe457318b6c4bed6791422bbcec51ecc8265faff45c", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:PXD002757 licence not read", "asset:data:geo:PXD002757 not downloaded", "execution.not_run", "method.reader_named_unmapped", "method.student_t", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:student_t"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ronic myeloid leukemia - an insight from the proteomic analysis of human plasma.", "into predictive- or monitoring-biomarkers. A proteomic approach, two-dimensional gel electrophoresi", "onal gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose. Bas"], "order_basis": "paper_text_order:64", "id": "assay:1"}, {"role": "data_generation", "definition_id": "elisa", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["nge with identifier PXD002757]. Quantitative ELISA, used for validation of candidate proteins b", "udies by enzyme linked immunosorbant assays (ELISA). To minimize sample handling bias or pipett", "andling bias or pipetting errors, pre-coated ELISA plates against human AAT (also called SERPIN"], "order_basis": "paper_text_order:1078", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Student's t-test"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}